Pancreatic Cancer Research

ResearcherCharles UniversityNo recent work listed

Miroslav Ryska

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1861-8506; OpenAlex author ID A5010835235. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 9

  1. Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. Co-author DOI 10.4149/neo_2023_230409n193↗
  2. [Pancreatic cancer - current effective diagnostic and therapeutic approach]. Co-author PMID 26898790↗
  3. [Current status regarding surgical treatment of pancreatic cancer in the Czech Republic]. Co-author PMID 27226268↗
  4. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  5. [Irreversible electroporation in the treatment of locally advanced pancreatic cancer]. Last author PMID 26767900↗
  6. Physical activity and risk of pancreatic cancer in a central European multicenter case-control study. Co-author DOI 10.1007/s10552-014-0370-x↗
  7. Pancreatic fistula and postoperative pancreatitis after pancreatoduodenectomy for pancreatic cancer. Co-author DOI 10.3978/j.issn.2304-3881.2014.09.05↗
  8. Body mass index and body size in early adulthood and risk of pancreatic cancer in a central European multicenter case-control study. Co-author DOI 10.1002/ijc.25959↗
  9. Superoxide dismutase and nicotinamide adenine dinucleotide phosphate: quinone oxidoreductase polymorphisms and pancreatic cancer risk. Co-author DOI 10.1097/mpa.0b013e3181f74ad7↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Z Krška · 3 shared papers, 2015–2023 · strength 0.28
  2. Pavel Záruba · 2 shared papers, 2015–2023 · strength 0.23
  3. David Hoskovec · 2 shared papers, 2015–2023 · strength 0.23
  4. Lubos B. Petruzelka · 1 shared paper, 2023 · strength 0.17
  5. Jan Ulrych · 1 shared paper, 2023 · strength 0.17
  6. Soňa Argalácsová · 1 shared paper, 2023 · strength 0.17
  7. Michal Vočka · 1 shared paper, 2023 · strength 0.17
  8. J Rudiš · 1 shared paper, 2014 · strength 0.09
  9. Arnošt Martínek · 2 shared papers, 2011–2014 · strength 0.06
  10. Paul Brennan · 2 shared papers, 2011–2014 · strength 0.06
  11. Vladimí­r Janout · 2 shared papers, 2011–2014 · strength 0.06
  12. Ghislaine Scélo · 2 shared papers, 2011–2014 · strength 0.06
  13. R Havlík · 1 shared paper, 2016 · strength 0.04
  14. Jan Hlavsa · 1 shared paper, 2016 · strength 0.04
  15. R Gürlich · 1 shared paper, 2016 · strength 0.04
  16. Č Neoral · 1 shared paper, 2016 · strength 0.04
  17. Martin Loveček · 1 shared paper, 2016 · strength 0.04
  18. Darren R. Brenner · 1 shared paper, 2014 · strength 0.04
  19. Pavel Souček · 1 shared paper, 2011 · strength 0.03
  20. Beatrice Mohelníková-Duchoňová · 1 shared paper, 2011 · strength 0.03
  21. Kevin Y. Urayama · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.